Literature DB >> 7660404

Differences between treated and untreated hypertensive subjects in the extent of periventricular hyperintensities observed on brain MRI.

H Fukuda1, M Kitani.   

Abstract

BACKGROUND AND
PURPOSE: Several reports have stated that the periventricular abnormalities found on T2-weighted MRI or CT are associated with age and hypertension. However, there have been no reports on the effect of hypertension treatment on white matter abnormalities. We studied the association between cardiovascular risk factors and periventricular hyperintensities (PVHs) on T2-weighted MRI and the differences between treated and untreated hypertensive subjects in the extent of PVHs.
METHODS: The extent of PVH observed on 238 MRI scans was assessed retrospectively in 238 patients older than 40 years with the use of a five-point (0 to 4) classification scale. Hypertensive subjects were divided into two groups: patients receiving no or irregular treatment and patients receiving regular treatment for hypertension.
RESULTS: Age, hypertension, treatment of hypertension, and multiple cerebral vascular lesions on MRI correlated significantly and independently with the extent of PVH. Sex and diabetes mellitus did not correlate with PVH. The Mann-Whitney U test showed significantly more extensive PVH in subjects with no or irregular treatment of hypertension compared with normotensives (2.5 +/- 0.7 versus 1.9 +/- 0.6, P < .0001) and compared with subjects receiving regular treatment of hypertension (2.5 +/- 0.7 versus 2.1 +/- 0.5, P = .0019). The latter patients had more extensive PVH than normotensives, but the difference was not significant. Mean systolic and diastolic blood pressure differed significantly among the three groups.
CONCLUSIONS: Hypertension and age were major predictors of the extent of PVH. Regular treatment for hypertension appeared to prevent the progression of PVH.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7660404     DOI: 10.1161/01.str.26.9.1593

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  11 in total

1.  Diabetes and cognitive impairment. Clinical diagnosis and brain imaging in patients attending a memory clinic.

Authors:  Geert Jan Biessels; Aafke Koffeman; Philip Scheltens
Journal:  J Neurol       Date:  2005-11-14       Impact factor: 4.849

Review 2.  Differential aging of the brain: patterns, cognitive correlates and modifiers.

Authors:  Naftali Raz; Karen M Rodrigue
Journal:  Neurosci Biobehav Rev       Date:  2006-08-17       Impact factor: 8.989

Review 3.  Beyond rehabilitation: A prevention model of reserve and brain maintenance in multiple sclerosis.

Authors:  Rachel Brandstadter; Ilana Katz Sand; James F Sumowski
Journal:  Mult Scler       Date:  2019-09       Impact factor: 6.312

4.  Influence of vascular risk factors on executive function among an age-homogeneous elderly cohort.

Authors:  Nazanin Sédille-Mostafaie; S Zehetmayer; W Krampla; W Krugluger; P Fischer
Journal:  J Neural Transm (Vienna)       Date:  2015-03-11       Impact factor: 3.575

5.  A Comparison of Cognitive and Everyday Functional Performance among Older Adults With and Without Hypertension.

Authors:  Elizabeth M Hudak; Jerri D Edwards; Ponrathi Athilingam; Cathy L McEvoy
Journal:  Clin Gerontol       Date:  2013       Impact factor: 2.619

Review 6.  Cerebral white matter lesions in essential hypertension.

Authors:  C Sierra
Journal:  Curr Hypertens Rep       Date:  2001-10       Impact factor: 5.369

7.  Automated measurement of brain and white matter lesion volume in type 2 diabetes mellitus.

Authors:  C Jongen; J van der Grond; L J Kappelle; G J Biessels; M A Viergever; J P W Pluim
Journal:  Diabetologia       Date:  2007-05-11       Impact factor: 10.122

Review 8.  Asymptomatic Cerebral Small Vessel Disease: Insights from Population-Based Studies.

Authors:  Alvin S Das; Robert W Regenhardt; Meike W Vernooij; Deborah Blacker; Andreas Charidimou; Anand Viswanathan
Journal:  J Stroke       Date:  2019-04-17       Impact factor: 6.967

9.  Plasma NT-proBNP and white matter hyperintensities in type 2 diabetic patients.

Authors:  Henrik Reinhard; Ellen Garde; Arnold Skimminge; Per Åkeson; Thomas Zoëga Ramsøy; Kaj Winther; Hans-Henrik Parving; Peter Rossing; Peter K Jacobsen
Journal:  Cardiovasc Diabetol       Date:  2012-10-03       Impact factor: 9.951

10.  The Association between Cerebral White Matter Lesions and Plasma Omega-3 to Omega-6 Polyunsaturated Fatty Acids Ratio to Cognitive Impairment Development.

Authors:  Michihiro Suwa; Shigeru Yamaguchi; Tsuyoshi Komori; Sachiko Kajimoto; Masaya Kino
Journal:  Biomed Res Int       Date:  2015-10-25       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.